Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.470 | 6.400 | 4.930 |
Shares | 98.530 | 98.530 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 24.346 | 20.691 |
Price to Book | 5.568 | 3.827 |
Price to Sales | 4.335 | 2.574 |
Price to Cash Flow | 17.067 | 14.022 |
Dividend Yield | 1.117 | 1.586 |
5 Years Earnings Growth | 13.249 | 11.901 |
Name | Net % | Category Average |
---|---|---|
Technology | 31.340 | 28.146 |
Communication Services | 17.160 | 8.163 |
Financial Services | 14.430 | 16.734 |
Healthcare | 13.670 | 13.082 |
Consumer Cyclical | 10.360 | 9.975 |
Consumer Defensive | 5.570 | 5.685 |
Industrials | 4.120 | 8.590 |
Energy | 3.330 | 3.681 |
Number of long holdings: 178
Number of short holdings: 120
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 7.99 | 432.11 | +0.69% | |
NVIDIA | US67066G1040 | 6.66 | 123.51 | +2.18% | |
Alphabet A | US02079K3059 | 5.58 | 161.49 | -0.49% | |
Eli Lilly | US5324571083 | 5.11 | 924.56 | +0.01% | |
Meta Platforms | US30303M1027 | 4.49 | 568.31 | +0.88% | |
Netflix | US64110L1061 | 3.58 | 721.56 | -0.10% | |
Merck&Co | US58933Y1055 | 2.94 | 114.73 | -0.20% | |
Elevance Health | US0367521038 | 2.81 | 520.49 | -1.30% | |
Adobe | US00724F1012 | 2.66 | 517.90 | -1.18% | |
Visa A | US92826C8394 | 2.49 | 269.63 | -1.15% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU0557291076 | 6.48B | 11.23 | 1.66 | 8.56 | ||
LU0947062542 | 5.68B | 8.55 | -8.34 | 0.09 | ||
LU0248185604 | 4.82B | 20.47 | 12.04 | 14.01 | ||
LU0248185513 | 4.82B | 19.39 | 10.53 | 12.56 | ||
LU0271483876 | 4.82B | 18.70 | 6.18 | 9.18 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review